Abstract
Myasthenia gravis (MG) is a rare autoimmune disease that is potentially threatening for patient life. Auto-antibodies targeting structures of the neuromuscular junction, particularly the acetylcholine receptor (AchR), are often found in the serum of MG patients. New-onset MG after SARS-CoV-2 vaccination has rarely been reported since the introduction of vaccination. Infections and COVID-19 infection have also been reported as possible triggers for a myasthenic crisis. We report a case of new-onset MG after receiving the mRNA COVID-19 vaccination. The patient was a 73-year-old male initially presenting with ocular symptoms and a rapid generalization. We also performed a literature revision of 26 described cases of MG after SARS-CoV-2 immunization. The patients were a majority of males with generalized late-onset MG occurring after the first dose of vaccine, similar to our patient. Only our patient showed a thymoma. Thymic mass and the positivity of AchR antibodies suggest that vaccination might have triggered a subclinical pre-existing MG with symptoms flaring. Clinicians should be aware of possible new-onset MG after COVID-19 vaccination, particularly in at-risk patients. Even though COVID-19 vaccination should be recommended in MG patients, particularly in well-compensated patients. However, more studies need to be performed in the future.
Subject
Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health
Reference51 articles.
1. Evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as coronavirus disease 2019 (COVID-19) pandemic: A global health emergency;Acter;Sci. Total Environ.,2020
2. Tondo, G., Virgilio, E., Naldi, A., Bianchi, A., and Comi, C. (2022). Safety of COVID-19 Vaccines: Spotlight on Neurological Complications. Life, 12.
3. Review of COVID-19 vaccine subtypes, efficacy and geographical distributions;Francis;Postgrad. Med. J.,2022
4. Hasanzad, M., Namazi, H., and Larijani, B. (2022). COVID-19 anti-vaccine attitude and hesitancy. J. Diabetes Metab. Disord., 1–4.
5. (2022, October 15). Causality Assessment of an Adverse Event Following Immunization (AEFI): User Manual for the Revised WHO Classification. Available online: https://www.who.int/publications-detail-redirect/9789241516990.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献